Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 5, 1988 - Issue 2
Submit an article Journal homepage
7
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Improved Prognosis for Children with Stage IV Neuroblastoma: High-Dose Melphalan and Autologous Unpurged Marrow Transplantation after Aggressive Surgery and Short Chemotherapy with Cisplatinum and Etoposide

Jukka Rajantie Children's Hospital, University of Helsinki, SF-00290, Helsinki, Finland
,
Sakari Wikström Children's Hospital, University of Helsinki, SF-00290, Helsinki, Finland
,
Mikko Perkkiö Children's Hospital, University of Helsinki, SF-00290, Helsinki, Finland
,
Liisa Hovi Children's Hospital, University of Helsinki, SF-00290, Helsinki, Finland
,
Anne Mäkipernaa Children's Hospital, University of Helsinki, SF-00290, Helsinki, Finland
,
Eeva-Liisa Maunuksela Children's Hospital, University of Helsinki, SF-00290, Helsinki, Finland
&
Martti A. Siimes Children's Hospital, University of Helsinki, SF-00290, Helsinki, Finland
 show all
Pages 125-135 | Received 17 Aug 1987, Accepted 21 Dec 1987, Published online: 09 Jul 2009

References

  • Hayes F A, Green A A. Neuroblastoma. Pediatr Ann 1983; 12: 366–373
  • Rosen E M, Cassady J R, Frantz C N. Neuroblastoma: The Joint Center for Radiation Therapy/Dana-Farber Cancer Institute/Children's Hospital Experience. J Clin Oncol 1984; 2: 719–732
  • Pritchard J, McElwain T J, Graham-Pole J. High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma. Br J Cancer 1981; 45: 86–94
  • Graham-Pole J, Lazarus H M, Herzig R H. High-dose melphalan therapy for the treatment of children with refractory neuroblastoma and Ewing's sarcoma. Am J Pediatr Hematol Oncol 1984; 6: 17–26
  • August C S, Ft Serota, Koch P A. Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation, and allogeneic or autologous marrow reconstitution. J Clin Oncol 1984; 2: 609–616
  • Shafford E A, Rogers D W, Pritchard J. Advanced neuroblastoma: Improved response rate using a multiagent regime (OPEC) including sequential cis-platinum and VM 26. J Clin Oncol 1984; 2: 742–747
  • Bagnulo S, Perez D J, Barrett A. High dose melphalan and autologous bone marrow transplantation for solid tumors of childhood. Eur Paediatr Haematol Oncol 1985; 2: 129–133
  • Philip T, Bernard J L, Zucker J M. High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: An unselected group of stage IV patients over 1 year of age. J Clin Oncol 1987; 5: 266–271
  • Hartmann O, Benhamou E, Beaujean F. Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma. J Clin Oncol 1987; 5: 1205–1211
  • Evans A E, D'Anglo G J, Randolph J G. A proposed staging for children with neuroblastoma. Cancer 1971; 27: 374–378
  • Treuner J, Feine U, Niethammer D. Scintigraphic imaging of neuroblastoma with (131I) iodobenzylguanedine. Lancet 1984; i: 333–334
  • Nitschke R, Starling K A, Vats T. Cis-diamminedichloroplatinum (NSC-119875) in childhood malignancies. A Southwest Oncology Group Study. Med Pediatr Oncol 1978; 4: 127–132
  • O'Dwyer P J, Leyland-Jones B, Alonso M T. Etoposide (VP-16–213): Current status of an active anticancer drug. N Engl J Med 1985; 312: 692–700
  • Ninane J, Baurain R, De Selys A. High dose melphalan in children with advanced malignant disease. A pharmocokinetic study. Cancer Chemother Pharmacol 1985; 15: 263–267
  • Kajanti M. Neuroblastoma in 88 children: Clinical features, prognostic factors, results and late effects of therapy. Ann Clin Res 1983; 15Suppl 39: 27–38
  • Pritchard J, Germond S, Jones D. Is high dose melphalan of value in treatment of advanced neuroblastoma? Preliminary results of a randomized trial by the European Neuroblastoma Study Group. Proc Am Soc Clin Oncol 1986; 5: 205
  • Koop C E, Johnson D G. Neuroblastoma: An assessment of therapy in reference to staging. J Pediatr Surg 1971; 6: 595–600
  • Hayes F A, Green A, Hustu H O, Kumar M. Surgicopathologic staging of neuroblastoma: Prognostic significance of regional lymph node metastases. J Pediatr 1983; 102: 59–62
  • Tourneau J N, Bernard J L, Hendren W H, Carcassone M. Evaluation of the role of surgery in 130 patients with neuroblastoma. J Pediatr Surg 1985; 20: 244–249
  • Grosfeld J, Schatzlein M, Ballantine T. Metastatic neuroblastoma: Factors influencing survival. J Pediatr Surg 1978; 13: 59–65
  • Grosfeld J L, Ballantine T VN, Baehner R L. Experience with “second-look” operations in pediatric solid tumors. J Pediatr Surg 1978; 13: 275–280
  • Carlsen N LT, Christensen I J, Schroeder H. Prognostic value of different staging systems in neuroblastoma and completeness of tumour excision. Arch Dis Child 1986; 61: 832–842
  • Treuner J, Feine U, Buck J. Clinical experiences in the treatment of neuroblastoma with 131I-metaiodobenzylguanidine. Pediatr Hematol Oncol 1986; 3: 205–216
  • Kemshead J T, Goldman A, Fritschy J. Use of panels of monoclonal antibodies in the differential diagnosis of neuroblastoma and lymphoblastic disorders. Lancet 1983; i: 12–15
  • Saarinen U, Coccia P F, Gerson S L. Eradication of neuroblastoma cells in vitro by monoclonal antibody and human complement: Method for purging autologous bone marrow. Cancer Res 1985; 45: 5969–5975
  • Treleaven J G, Kemshead J T. Removal of tumor cells from bone marrow. An evaluation of the available methods. Hematol Oncol 1985; 3: 65–75
  • Glorieux P, Bouffet E, Philip I. Metastatic interstitial pneumonitis after autologous bone marrow transplantation. A consequence of reinjection of malignant cells. Cancer 1986; 58: 2136–2139
  • Weiden P L, Sullivan K M, Flournoy N. Antileukemic effect of chronic graft-versus-host disease: Contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 1981; 304: 1529–1533

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.